Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2469150 | 1.00 | TP53 (0.33) | TP53 | |
| SCHEMBL26715533 | 1.00 | TP53 (0.33) | TP53 | |
| SCHEMBL6027888 | 1.00 | TP53 (0.33) | TP53 | |
| SCHEMBL7154730 | 1.00 | TP53 (0.33) | TP53 | |
| SCHEMBL14060702 | 1.00 | TP53 (0.33) | TP53 | |
| SCHEMBL17570468 | 0.97 | TP53 (0.32) | TP53 | |
| Acetic Acid SCHEMBL27945447 | 0.95 | FFAR3 (0.37) | TP53 | |
| SCHEMBL13703412 | 0.91 | TP53 (0.35) | TP53 | |
| SCHEMBL12572606 | 0.87 | LMNA (0.36) | TP53 | |
| SCHEMBL13997319 | 0.87 | LMNA (0.36) | TP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 179 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20140127735-A1 | CHARACTERIZATION OF N-GLYCAN MIXTURES BY NUCLEAR MAGNETIC RESONANCE | MOMENTA PHARMACEUTICALS, INC. (US) | 2014-05-08 | — | — | US | claimed |
| US-8663999-B2 | Characterization of N-glycan mixtures by nuclear magnetic resonance | MOMENTA PHARMACEUTICALS, INC. (US) | 2014-03-04 | — | — | US | claimed |
| US-20130069645-A1 | CHARACTERIZATION OF N-GLYCAN MIXTURES BY NUCLEAR MAGNETIC RESONANCE | MOMENTA PHARMACEUTICALS, INC. (US) | 2013-03-21 | — | — | US | claimed |
| US-8216851-B2 | Characterization of N-glycan mixtures by nuclear magnetic resonance | MOMENTA PHARMACEUTICALS, INC. (US) | 2012-07-10 | — | — | US | claimed |
| EP-2135088-A1 | CHARACTERIZATION OF N-GLYCAN MIXTURES BY NUCLEAR MAGNETIC RESONANCE | Momenta Pharmaceuticals, Inc. (US) | 2009-12-23 | — | — | EP | claimed |
| WO-2008128218-A1 | CHARACTERIZATION OF N-GLYCAN MIXTURES BY NUCLEAR MAGNETIC RESONANCE | MOMENTA PHARMACEUTICALS, INC. (US) | 2008-10-23 | — | — | WO | claimed |
| US-12616198-B2 | Lipo-chitooligosaccharide compositions for enhancing plant growth | NOVOZYMES BIOAG A/S (DK) | 2026-05-05 | — | — | US | disclosed |
| US-12552727-B2 | Seed treatment methods and compositions | NOVOZYMES BIOAG A/S (DK) | 2026-02-17 | — | — | US | disclosed |
| US-20260035314-A1 | USE OF PHOSPHATE-SOLUBILIZING MICROORGANISMS AND LIPO-CHITOOLIGOSACCHARIDES FOR ENHANCING PLANT GROWTH | Novonesis Plant Biosolutions A/S (DK) | 2026-02-05 | — | — | US | disclosed |
| US-12459875-B2 | Use of phosphate-solubilizing microorganisms and lipo-chitooligosaccharides for enhancing plant growth | NOVOZYMES BIOAG A/S (DK) | 2025-11-04 | — | — | US | disclosed |
| EP-3065545-B1 | COMPOSITIONS AND METHODS FOR CONTROLLING PESTS | DANSTAR FERMENT AG (CH) | 2025-08-13 | — | — | EP | disclosed |
| US-12185720-B2 | Chitooligosaccharides and methods for use in enhancing plant growth | NOVOZYMES BIOAG A/S (DK) | 2025-01-07 | — | — | US | disclosed |
| US-20240300868-A1 | USE OF PHOSPHATE-SOLUBILIZING MICROORGANISMS AND LIPO-CHITOOLIGOSACCHARIDES FOR ENHANCING PLANT GROWTH | Novonesis Plant Biosolutions A/S (DK) | 2024-09-12 | — | — | US | disclosed |
| US-5646018-A | LIPOOLYGOSACCHARIDES; INTERACT WITH ROOTS OF LEGUMES TO FIX ATMOSPHERIC NITROGEN; PLANT TREATING AGENT | INSTITUT NATIONAL DE LA RECHERCHE AGRONOMIQUE - I.N.R.A. (FR) | 1997-07-08 | — | — | US | disclosed |
| EP-0729648-A4 | STABILISED ELECTROLYTE SOLUTIONS, METHODS OF PREPARATION THEREOF AND REDOX CELLS AND BATTERIES CONTAINING STABILISED ELECTROLYTE SOLUTIONS | UNISEARCH LTD (AU) | 1997-01-02 | — | — | EP | disclosed |
| WO-1996035239-A1 | HIGH ENERGY DENSITY VANADIUM ELECTROLYTE SOLUTIONS, METHODS OF PREPARATION THEREOF AND ALL-VANADIUM REDOX CELLS AND BATTERIES CONTAINING HIGH ENERGY VANADIUM ELECTROLYTE SOLUTIONS | UNISEARCH LIMITED (AU) | 1996-11-07 | — | — | WO | disclosed |
| EP-0729648-A1 | STABILISED ELECTROLYTE SOLUTIONS, METHODS OF PREPARATION THEREOF AND REDOX CELLS AND BATTERIES CONTAINING STABILISED ELECTROLYTE SOLUTIONS | UNISEARCH LIMITED (AU) | 1996-09-04 | — | — | EP | disclosed |
| WO-1995012219-A1 | STABILISED ELECTROLYTE SOLUTIONS, METHODS OF PREPARATION THEREOF AND REDOX CELLS AND BATTERIES CONTAINING STABILISED ELECTROLYTE SOLUTIONS | UNISEARCH LIMITED (AU) | 1995-05-04 | — | — | WO | disclosed |
| EP-0648219-A1 | BROAD HOST SPECTRUM RHIZOBIACEAE NODULATION SIGNALS | INSTITUT NATIONAL DE LA RECHERCHE AGRONOMIQUE (INRA) (FR) | 1995-04-19 | — | — | EP | disclosed |
| WO-1994000466-A1 | BROAD HOST SPECTRUM RHIZOBIACEAE NODULATION SIGNALS | INSTITUT NATIONAL DE LA RECHERCHE AGRONOMIQUE - I.N.R.A. (FR) | 1994-01-06 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240300868-A1 | USE OF PHOSPHATE-SOLUBILIZING MICROORGANISMS AND LIPO-CHITOOLIGOSACCHARIDES FOR ENHANCING PLANT GROWTH | DDOST, PGLS, CHIT1 | TP53 3544/4885 |
| US-20260035314-A1 | USE OF PHOSPHATE-SOLUBILIZING MICROORGANISMS AND LIPO-CHITOOLIGOSACCHARIDES FOR ENHANCING PLANT GROWTH | PGLS, IPMK, PLCD1 | TP53 3518/4885 |
| US-12459875-B2 | Use of phosphate-solubilizing microorganisms and lipo-chitooligosaccharides for enhancing plant growth | DDOST, PGLS, CHIT1 | TP53 3544/4885 |
| US-12552727-B2 | Seed treatment methods and compositions | MYB, FER, BOLA2; BOLA2B | TP53 4744/4885 |
| US-12616198-B2 | Lipo-chitooligosaccharide compositions for enhancing plant growth | GHDC, PGLS, CHIT1 | TP53 3892/4885 |
| US-12185720-B2 | Chitooligosaccharides and methods for use in enhancing plant growth | CHIT1, ALG1, GALE | TP53 4871/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.